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Abstract
There is good evidence that forebrain serotonergic systems modulate cognitive ﬂexibility. Latent
inhibition (LI) is a cross-species phenomenon which manifests as poor conditioning to a stimulus that
has previously been experienced without consequence and is widely considered an index of the ability to
ignore irrelevant stimuli. While much research has focused on dopaminergic mechanisms underlying LI,
there is also considerable evidence of serotonergic modulation. However, the neuroanatomical locus of
these eﬀects remains poorly understood. Previous work has identiﬁed the nucleus accumbens (NAc) as
a key component of the neural circuit underpinning LI and furthermore, this work has shown that
the core and shell subregions of the NAc contribute diﬀerentially to the expression of LI. To examine the
role of the serotonergic input to NAc in LI, we tested animals with 5,7-dihydroxytryptamine (5,7-DHT)
lesions to the core and shell subregions on LI assessed under experimental conditions that produce LI
in shams and subsequently with weak stimulus pre-exposure designed to prevent the emergence of LI in
shams. We found that serotonergic deaﬀerentation of the core disrupted LI whereas 5,7-DHT lesions to the
shell produced the opposite eﬀect and potentiated LI.
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Introduction
Prior exposure to a stimulus without consequence
retards the acquisition of a conditioned response to
that stimulus when it is subsequently paired with a
biologically signiﬁcant event (Lubow & Moore, 1959).
This latent inhibition (LI) eﬀect is reliably disrupted
by the indirect catecholamine agonist amphetamine
in both humans and rodents and is absent in acute
schizophrenia patients (Baruch et al. 1988; Gray et al.
1992; Kumari et al. 1999; Solomon et al. 1981; Weiner
et al. 1984). Disrupted LI is reversed by both typical
and atypical antipsychotics that also potentiate LI
(Shadach et al. 2000; Weiner & Feldon, 1987; Williams
et al. 1997). As a loss of selectivity in attentional pro-
cesses is considered a hallmark of schizophrenia,
the neural substrates of LI have aroused considerable
interest in recent years (Gray et al. 1991, 1997,
1999; Weiner, 1990, 2003). Much of this work has
focused on the role of forebrain dopaminergic
systems and related corticolimbic structures. These
studies have shown that the nucleus accumbens
(NAc) and its dopamine (DA) innervation as well as
major sources of input to the NAc including entorhinal
cortex, medial prefrontal cortex (mPFC), hippocampus
and basolateral amygdala all play a key role in
the regulation of LI (Coutureau et al. 1999; Gal et al.
2005; George et al. 2010; Honey & Good, 1993; Nelson
et al. 2010, 2011a, b; Schiller & Weiner, 2004; Tai et al.
1995).
There is also compelling evidence of serotonergic
modulation of LI. Central serotonin (5-HT) depletion
induced by electrolytic lesions as well as 5,7-
dihydroxytryptamine (5,7-DHT) lesions to the medial
raphe nucleus attenuate LI (Asin et al. 1980; Lorden
et al. 1983; Solomon et al. 1980). Similarly, pharmaco-
logical manipulations designed to reduce 5-HT trans-
mission or block its actions post-synaptically have
generally been shown to disrupt LI (Cassaday et al.
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whereas increases in 5-HT release can potentiate LI
(Loskutova, 1998). However, little work has addressed
the neuroanatomical locus of these eﬀects. One study
has shown that destruction of 5-HT hippocampal in-
nervation by 5,7-DHT lesions to the fornix-ﬁmbria at-
tenuates LI (Cassaday et al. 1993b). More recently,
there has been some evidence that 5,7-DHT lesions to
the NAc can similarly disrupt LI (Loskutova, 2001).
However, it is clear from studies that have employed
electrolytic and excitotoxic lesions that the core and
shell subregions of the NAc are diﬀerentially involved
in LI: LI is abolished by shell lesions but spared or
potentiated by core lesions (Gal et al. 2005; Tai et al.
1995; Weiner et al. 1996).
Thus to dissociate the potential role of 5-HT within
diﬀerent neuroanatomical subdivisions of the NAc,
we tested the eﬀects of 5,7-DHT lesions to serotonergic
terminals within the core and medial shell NAc on LI
measured in a conditioned emotional response pro-
cedure. As the eﬀects of neural manipulations on LI
may only emerge with the use of appropriate exper-
imental parameters that can reveal lesion-induced
abolition or potentiation of LI (Nelson et al. 2010;
Weiner & Arad, 2009), we tested the eﬀects of the 5,7-
DHT lesions under conditions that produce robust LI
in controls (30 stimulus pre-exposures in expt 1) as
well as with parameters designed to prevent the
emergence of LI in normal rats (10 stimulus pre-
exposures in expt 2).
Methods
Animals
The subjects were 68 adult male Wistar rats (Charles
River, UK) that were caged in pairs on a 12-h light/
dark cycle (lights on 07:00 hours) with food and
water available ad libitum. Rats were handled for ap-
proximately 10 min per day for 1 wk and then at
mean weight 242 g (range 213–263 g) underwent
surgery. Twenty-three rats were randomly allocated
to the core group and 24 to the shell group and a
total of 21 rats were allocated to the sham condition
(11 rats were sham-operated at the core coordinates
and 10 rats were sham-operated at the shell co-
ordinates).
All procedures were carried out in accordance
with the United Kingdom (UK) Animals Scientiﬁc
Procedures Act 1986, Project License no.: PPL 40/
3163. The UK Act ensures full compliance with the
‘Principles of laboratory animal care’ (NIH publi-
cation No. 86-23, revised 1985).
Stereotaxic infusion of 5,7-dihydroxytryptamine
In order to protect dopaminergic terminals, animals
received injections of the DA reuptake inhibitor
GBR12909 (15 mg/kg). The NA reuptake inhibitor
desipramine (25 mg/kg) was also administered to
protect noradrenergic terminals. Both desipramine
and GBR12909 were administered by subcutaneous
injection approximately 30 min prior to the stereotaxic
infusion of 5,7-DHT. Anaesthesia was induced
by isoﬂurane (4%) in a N2O/O2 (1:2, v/v) mixture and
maintained thereafter with isoﬂurane (1–2%). Stereo-
taxic surgery was conducted with the incisor bar set
at x3.3 mm below the intra-aural line. The bone
above the NAc was removed and the dura was cut to
expose the cortex. Rats received bilateral infusions of
5,7-DHT or vehicle into either core or medial shell
at the following stereotaxic coordinates – core: AP
+1.6 mm, ML ¡1.8 mm, DV x6.8 mm; medial shell:
AP +1.3 mm, ML ¡0.8 mm, DV x6.4 and 7.0 mm;
one infusion at each DV coordinate (Paxinos &
Watson, 2005). DV coordinates were taken from
dura. Infusions were made via a 31-gauge stainless-
steel injector attached by polythene tubing to a 1 ml
Hamilton syringe. 5,7-DHT creatinine sulfate
(15 mg/ml as salt dissolved in vehicle; Sigma, UK) or
vehicle (0.9% saline/ascorbic acid, 0.2% w/v) was
infused manually over 2 min in a volume of 0.5 ml
(core) or as two infusions of 0.25 ml (medial shell). The
injectors were left in situ for 5 min to allow absorption
of the bolus and to minimize spread of the toxin.
Control animals were injected with the saline vehicle
at shell or core coordinates and otherwise treated
identically. Rimadyl (0.03 ml s.c.) provided post-
operative analgesia. Animals were allowed a mini-
mum of 7 d recovery before the commencement of
behavioural testing.
Quantiﬁcation of 5,7-DHT lesion by high-pressure
liquid chromatography with electrochemical
detection (HPLC-ECD)
Following the completion of behavioural testing, the
rats were humanely killed by dislocation of the neck
and decapitated. The brains were removed rapidly
and dissected on a cold tray. Using ice-chilled razor
blades, three 2-mm coronal brain sections were cut.
The posterior side of the slices corresponded to ap-
proximately +3, +1 and x3 from bregma according
to the atlas of Paxinos & Watson (2005). The brain
samples were then immediately frozen on dry ice and
stored at x80 xC. Subsequently, the three 2-mm coro-
nal sections were placed posterior side up onto an ice-
chilled plate. From the ﬁrst section (+3 mm bregma)
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used to remove the infralimbic (IL) cortex and the
prelimbic (PL) cortex from the same brain slice. From
the second section (+1 bregma), the 0.84-mm-
diameter stainless-steel micropunch was also used to
remove samples of tissue from core NAc and medial
shell NAc and a 1.6-mm-diameter stainless-steel
micropunch was used to remove sample tissue from
the caudate putamen (CPu). From the third section
(x3 mm bregma) a 1.6-mm-diameter stainless-steel
micropunch was used to remove the amygdala. In
each case, one punch was used per brain hemisphere,
except in IL and PL cortices where hemisphere pun-
ches were combined. Tissue punch samples were
stored in 1.5 ml Eppendorf tubes and frozen at
x80 xC.
Neurotransmitter levels in the samples were deter-
mined by HPLC-ECD. The tissue samples were hom-
ogenized in 0.1 M PCA solution by sonication and
centrifuged at 17400 g for 20 min at 4 xC. The super-
natant was injected onto the HPLC system. The mobile
phase consisted of 50 mM citric acid, 0.1 mM EDTA,
8m M KCl, 50 mM phosphoric acid, 30 mg/l octane-
sulfonic acid, and 6% methanol, pH adjusted to 4.15 by
the addition of sodium hydroxide. The mobile phase
was pumped at a ﬂow rate of 0.2 ml/min by an Alexys
LC100 pump connected via an Alexys AS100 auto-
sampler to an Antec Leyden reverse-phase analytical
column (ALF-215 150r2.1 mm i.d.) maintained at
35 xC. Neurotransmitter levels were detected using a
glassy carbon ﬂow cell (VT-03 Antec) with an ISAAC
Ag/AgCl reference electrode. An external standard
consisting of DA and 5-HT and their metabolites
in concentrations of 10x7, 0.5r10x7 and 10x8 M was
injected at a volume of 4 ml for calibration. Samples
were injected onto the column at 4 ml volumes, except
forPLandILsampleswhichwereinjectedat8 mldueto
the higher detection thresholds in the mPFC. Results
were analysed using Alexys software data system.
Bradford assay was used to adjust for protein content
using the pellet remaining after sample centrifugation.
Latent inhibition
Apparatus
Six identical fully automated conditioning chambers,
housed within sound-attenuating cases containing
ventilation fans (Cambridge Cognition, Cambridge,
UK) were used. Each of the inner conditioning
chambers consisted of a plain steel box (25r25r22 cm
high) with a Plexiglas door (27r21 cm) at the front.
The ﬂoor was a shock grid with steel bars 1 cm apart
and 1 cm above the lip of a 7-cm-deep sawdust tray.
A waterspout was mounted on one wall. The spout
was 5 cm above the ﬂoor and connected to a
lickometer supplied by a pump. Licks were registered
as a break in the photo beam within the spout, which
also triggered water delivery of 0.05 ml per lick.
The waterspout was illuminated when water was
available. A loudspeaker for the presentation of audi-
tory stimuli was set in the roof. A 5-s ﬂashing light,
provided by the three wall-mounted stimulus lights
and the house-light ﬂashing both on (0.5 s) and oﬀ
(0.5 s) served as the conditioned stimulus (CS) in expt
1.Inexpt2,toavoidgeneralizationacrossexperiments,
the CS was a 5-s mixed-frequency noise set at 85 dB
(including background). Footshock of 1 s duration
and 1 mA intensity provided the unconditioned
stimulus (UCS) in both experiments. This was de-
livered through the grid ﬂoor by a constant current
shock generator (pulsed voltage: output square wave
10 ms on, 80 ms oﬀ, 370 V peak under no load condi-
tions; MISAC Systems, UK). Stimulus control and data
collection were by an Acorn Archimedes RISC com-
puter programmed in Basic with additional interfacing
using an Arachnid extension (Cambridge Cognition).
Procedure
Expt 1: LI assessed with 30 CS pre-exposures (light CS)
Waterdeprivationwasintroduced1dpriortoshaping.
Thereafter, the animals received 1 h and 15 min of
ad libitum access to water in their home cage in ad-
dition to water in the experimental chambers. The
stages of the conditioned emotional response (CER)
procedure used in expt 1 were as follows:
Pre-training. Rats were shaped for 1 d until all drank
from the waterspout and individually assigned to a
conditioning box for the duration of the experiment.
There then followed 5 d of pre-training, in which rats
drank in the experimental chamber for 15 min each
day (timed from ﬁrst lick). The drinking spout was
illuminated throughout, but no other stimuli were
presented in this phase. Latency to ﬁrst lick was
measured as an indicator of habituation to the
experimental context. Total number of licks was
also recorded each day to assess any pre-existing
diﬀerences in drinking (prior to conditioning).
Pre-exposure with 30 CS presentations. Animals were
placed in the chambers where the pre-exposed (PE)
animals received thirty 5-s light CS presentations with
an average inter-stimulus interval of 60 s. The non-
pre-exposed (NPE) control animals were conﬁned to
the chambers for an identical period of time (30 min)
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was not available within the chamber and the
waterspout was not illuminated during the pre-
exposure session.
Conditioning. Conditioning was conducted on the
day following pre-exposure. No water was available
within the chamber and the waterspout was not
illuminated. There were two conditioning trials in
which the UCS footshock was delivered following
termination of the light CS. The ﬁrst pairing of CS and
UCS was presented after 5 min had elapsed, and the
second pairing was 5 min after the ﬁrst, followed by
a further 5 min left in the apparatus. In the absence
of drinking, there were no behavioural measures to
record.
Reshaping. On the day following conditioning,
animals were reshaped following the same procedure
as in pre-training sessions. This was in order to re-
establish drinking after conditioning. Reshaping also
provided measures of conditioning to the box context
(latency to ﬁrst lick).
Light test. On the day following reshape, the animals
were placed in the conditioning chambers and con-
ditioned suppression to the light was determined.
Water was available throughout the test and the
waterspout was illuminated. Once the animals had
made 50 licks, the light CS was presented for 15 min.
The latency to make 50 licks in the absence of the CS
(the A period) provided a measure of any individual
variation in baseline lick responding. This was
compared with the time taken to complete 50 licks
following CS onset (B period) in a suppression ratio
[A/(A+B)] to assess the level of conditioning to the
CS, adjusted for any individual variation in drinking
rate.
Expt 2: LI assessed with 10 CS pre-exposures (noise CS)
Following the completion of expt 1, the animals were
given one session of baseline training conducted in
exactly same manner as above. They then underwent
the same procedure as above except that the CS was
now a noise CS and the PE animals only received
10 CS presentations. Brieﬂy, the stages of expt 2 were
as follows:
Pre-exposure 10 CS presentations. This was conducted
in exactly the same manner as expt 1 except that the PE
animals received 10 CS presentations of the noise CS.
NPE controls remained in the box for 10 min without
any CS presentations.
Conditioning. This was as described above except the
CS was the 5-s noise CS.
Reshape. This was as described for expt 1.
Noise test. This was conducted in the same way as the
light test in expt 1 except that CS was the 5-s mixed-
frequency noise. As lesion-induced changes in the
level of LI after weak pre-exposure (i.e. enhanced LI)
are not always apparent after a single test of
conditioning to the CS, the animals underwent a
second test to the noise CS in expt 2 (Joseph et al.
2000; Nelson et al. 2011b).
Design and analysis. In each experiment, there were
six experimental groups run in a 3r2 independent
factorial design with lesion placement (at levels sham,
core or shell) and pre-exposure (levels of NPE and PE)
as between-subject factors. Statistical analysis was
performed using analysis of variance (ANOVA)
with alpha set at p<0.05 for the rejection of the
null hypothesis. Signiﬁcant interactions were ex-
plored with simple main eﬀects using the pooled
error term. In expt 2, the animals underwent two
tests of conditioning to the noise CS (Joseph et al.
2000). Thus the test data from expt 2 were subject
to an additional within-subjects factor with two
levels (test 1 and test 2). t tests were used to explore
diﬀerences between groups in neurotransmitter
levels.
Results
Neurochemical assay
Initial analysis revealed that three animals showed
no evidence of 5-HT depletion and a further 10 ani-
mals had only unilateral depletions. These animals
were therefore excluded from all subsequent neuro-
chemical and behavioural analyses. After these ex-
clusions, there were 15 shell-lesioned animals (8 NPE,
7 PE) with a mean 5-HT depletion of 65.5%
(range 95.2% to 30.2% loss) in the target structure
and 19 core-lesioned animals (11 NPE, 8 PE) with a
mean 5-HT depletion of 76.0% (range 95.7 to 48.7%
loss) in the target structure. There were 21 shams
(11 NPE, 10 PE).
The levels (pmol/mg protein) of 5-HT and DA as
well as their metabolites 5-HIAA and DOPAC in
the six brain regions from which samples were
taken are presented as absolute levels (Table 1)
and as the percentage depletion relative to sham
488 A. J. D. Nelson et al.levels (Table 2). As is clear from the tables, the
shell lesion was anatomically selective in that it
depleted 5-HT in the shell without any signiﬁcant
changes in the adjacent core. Injection of 5,7-DHT
into the core produced an overall larger depletion
in the target structure but also led to some 5-HT
loss in the shell sample (x33.4%). Both lesions
also resulted in signiﬁcant changes in 5-HT levels
in both subregions of the mPFC sample. However,
there was no evidence of 5-HT loss in the CPu
sample which was dorsal to the injection sites.
Although the shell lesion did lead to signiﬁcant in-
creases in DA levels measured in the core sample
(+54.6%), the 5,7-DHT lesions were otherwise
neurochemically selective to 5-HT, producing a
maximal loss of 25.4% in DA in the other brain regions
sampled, indicating that GBR12909 had protected DA
terminals.
Behavioural
Expt 1: LI assessed with 30 CS pre-exposures
Pre-conditioning. By day 5, there were no diﬀerences
between the lesion groups and the animals to be
conditioned in terms of the latency to ﬁrst lick or total
amount drunk (max F2,49=1.47, n.s.).
Reshape. There were no eﬀects of lesion or pre-
exposure on the latency to ﬁrst lick in the reshape
session following conditioning (max F2,49=1.51, n.s.).
Similarly, there were no diﬀerences in the total
number of licks made during the reshape session
(max F2,49=1.82, n.s.).
Table 1. Mean absolute levels (¡S.E.M.) of 5-HT and DA and their metabolites 5-HIAA
and DOPAC after 5,7-DHT lesions to either the core or shell NAc in the six brain
regions assayed. Values are expressed as pmol/mg protein
Vehicle 5,7-DHT core 5,7-DHT shell
5-HT
Core 0.556¡0.042 0.139¡0.024*# 0.609¡0.120
Shell 0.921¡0.086 0.632¡0.095*# 0.327¡0.049*#
Caudate putamen 0.299¡0.017 0.258¡0.018 0.301¡0.028
Amygdala 0.745¡0.039 0.808¡0.073 0.801¡0.043
Prelimbic cortex 0.351¡0.033 0.164¡0.028* 0.117¡0.170*
Infralimbic cortex 0.390¡0.034 0.163¡0.032* 0.112¡0.031*
5-HIAA
Core 0.756¡0.067 0.469¡0.078*# 0.995¡0.169#
Shell 0.878¡0.089 0.707¡0.073 0.596¡0.067*
Caudate putamen 0.512¡0.032 0.463¡0.027 0.530¡0.049
Amygdala 0.673¡0.043 0.703¡0.037 0.793¡0.031*#
Prelimbic cortex 0.487¡0.051 0.265¡0.037* 0.189¡0.022*
Infralimbic cortex 0.467¡0.069 0.243¡0.041 0.181¡0.034
DA
Core 10.545¡1.03 10.026¡1.12 15.15¡1.810*#
Shell 11.521¡1.63 8.650¡0.861 9.742¡1.960
Caudate putamen 8.990¡0.697 10.20¡0.887 9.343¡0.608
Amygdala 1.604¡0.190 1.682¡0.288 1.446¡0.242
Prelimbic cortex 0.202¡0.026 0.162¡0.013 0.181¡0.020
Infralimbic cortex 0.122¡0.012 0.097¡0.011 0.104¡0.009
DOPAC
Core 3.628¡0.373 4.475¡0.533 5.748¡0.683*#
Shell 4.635¡0.747 4.505¡0.554 5.682¡1.308
Caudate putamen 2.583¡0.249 3.739¡0.434* 3.599¡0.421
Amygdala 0.360¡0.051 0.366¡0.050 0.313¡0.036
Prelimbic cortex 0.062¡0.006 0.080¡0.010 0.079¡0.007
Infralimbic cortex 0.059¡0.007 0.065¡0.011 0.067¡0.012
*Signiﬁcant diﬀerence from sham,
#signiﬁcant diﬀerence from other lesion group, p<0.05, t test.
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absence of the light CS) did not diﬀer between any
of the groups (max F1,49=1.35, n.s.). The mean
suppression ratios to the light are presented in Fig. 1.
As expected with 30 CS pre-exposures, there was a
robust LI eﬀect in the sham-lesioned animals, but the
eﬀect of pre-exposure clearly diﬀered by lesion group.
This description of the data was conﬁrmed by
ANOVA which yielded no eﬀect of lesion (F<1), an
eﬀect of pre-exposure (F1,49=15.02, p=0.0003) but also
an interaction (F2,49=3.25, p=0.047). Simple eﬀects
analysis of this interaction conﬁrmed an eﬀect of
pre-exposure in the sham (F1,49=11.21, p=0.0016) and
shell-lesioned (F1,49=9.92, p=0.0028) animals, but in
the core-lesioned animals there was no diﬀerence in
conditioning to the light CS between the NPE and PE
animals (F<1).
Expt 2: LI assessed with 10 CS pre-exposures
Pre-conditioning. None of the experimental groups
diﬀered in terms of time to ﬁrst lick or total number
of licks (max F2,49=2.49, n.s.).
Reshape. Analysis of the times (s) to complete the ﬁrst
lick in the reshape session following conditioning
revealed no eﬀects of pre-exposure, lesion or an
interaction between these factors (max F2,49=1.86,
n.s.). Nor were there any diﬀerences between the
groups in the total number of licks made in the
reshape session (max F1,49=1.38, n.s.).
Noise test. None of the experimental groups diﬀered in
the time to make the ﬁrst lick in the absence of the tone
(A period) in either test (max F2,49=2.69, n.s.). Analysis
of the two tests revealed an eﬀect of test (F1,49=47.44,
p=0.0001) consistent with extinction to the CS. This
factor did not interact with either the pre-exposure or
lesion (max F1,49=1.55, n.s.) and hence the data are
presented in Fig. 2 collapsed across the two tests.
Inspection of this ﬁgure reveals that under conditions
of weak pre-exposure there was no evidence of LI
in shams. Similarly, the core NPE and PE animals
showed equivalent levels of conditioning to the CS.
However, 5,7-DHT lesions to the shell appeared to
potentiate LI as there was a clear pre-exposure eﬀect in
Table 2. Mean percentage (¡S.E.M.) depletions of 5-HT and
DA and their metabolites 5-HIAA and DOPAC after 5,7-DHT
lesions to either the core or shell NAc in the six brain regions
assayed.Percentages are expressedrelative to vehicle-infused
animals
5,7-DHT core 5,7-DHT shell
5-HT
Core x76.0%*#¡ 4.2 +13.5% ¡22.1
Shell x33.4%*#¡10.1 x65.5%*#¡ 5.3
Caudate putamen x9.7% ¡6.1 x3.2% ¡8.9
Amygdala +7.7% ¡9.7 ¡8.2% ¡5.9
Prelimbic cortex x54.5%* ¡7.9 x65.9%* ¡4.9
Infralimbic cortex x53.0%* ¡9.3 x73.0%* ¡7.8
5-HIAA
Core x42.4%*#¡ 9.5 +40.3%#¡ 23.6
Shell x21.4% ¡8.1 x30.8%* ¡7.7
Caudate putamen x8.1% ¡5.3 +2.3% ¡9.5
Amygdala x5.4% ¡5.0 +30.2%*#¡ 5.8
Prelimbic cortex x48.2%* ¡7.1 x59.7%* ¡4.4
Infralimbic cortex x42.7% ¡9.6 x63.5% ¡7.1
DA
Core x12.2% ¡9.8 +54.6%*#¡ 15.5
Shell x25.4% ¡7.4 x15.0% ¡17.1
Caudate putamen +8.3% ¡9.4 +8.4% ¡7.1
Amygdala x14.4% ¡14.6 +13.7% ¡19.7
Prelimbic cortex x23.2% ¡6.1 x6.4% ¡10.6
Infralimbic cortex x10.9% ¡10.0 x22.4% ¡6.8
DOPAC
Core +18.2% ¡13.8 +68.0%*#¡ 19.9
Shell x1.1% ¡12.2 x15.0% ¡17.1
Caudate putamen +50.1%* ¡17.4 +35.0 ¡15.6
Amygdala x17.3% ¡11.2 +9.5% ¡13.2
Prelimbic cortex +21.9% ¡15.5 +34.5% ¡12.8
Infralimbic cortex +26.2% ¡20.8 +0.9% ¡17.4
*Signiﬁcant diﬀerence from sham,
#signiﬁcant diﬀerence from other lesion group, p<0.05, t test.
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Fig. 1. The eﬀect of 5,7-DHT lesions to the core and shell of
the nucleus accumbens on latent inhibition produced with
30 conditioned-stimulus (CS) pre-exposures. Bars represent
suppression ratios (¡S.E.M.) to the CS for non-pre-exposed
controls (%) and pre-exposed animals ( ). Signiﬁcant
diﬀerence between pre-exposure groups (p<0.05).
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lesion or pre-exposure (max F1,49=1.61, n.s.) but a
signiﬁcant interaction between these factors (F2,49=
3.56, p=0.036). Simple eﬀects of this analysis
conﬁrmed the absence of LI in both the sham and
core-lesioned animals (both Fs <1) but a clear pre-
exposure eﬀect in shell-lesioned animals (F1,49=6.89,
p=0.012).
Discussion
The current experiments tested the eﬀects of 5-HT
depletion within the core and shell of NAc on LI using
experimental parameters designed to produce (expt 1)
and prevent (expt 2) the emergence of LI in sham-
lesioned animals. Under conditions that yielded re-
liable LI in shams, core but not shell 5-HT depletion
attenuated LI. Conversely, 5,7-DHT lesions to the shell
potentiated LI.
Neuroanatomical and neurochemical selectivity of
the 5,7-DHT lesions
The 5,7-DHT lesions to the medial shell were ana-
tomically highly selective in that they produced sig-
niﬁcant 5-HT depletions within the shell (x65.5%) but
only minimal changes in the adjacent core (+13%).
The core lesion depleted core 5-HT (x76.0%) but also
resulted in some 5-HT loss in the shell sample
(x33.4%). This pattern of greater anatomical selec-
tivity of shell lesions compared to core lesions is
consistent with what we and others have found with
6-hydroxydopamine (6-OHDA) lesions to the NAc
core and shell, although the selectivity of the core
5,7-DHT lesion in the present study was far greater
than that previously produced by 6-OHDA (Nelson
et al. 2011a; Sellings et al. 2008). There are direct con-
nections between the core and shell NAc, with par-
ticularly strong connections from the core to the shell
which may account for the greater anatomical selec-
tivity of the shell lesion (Van Dongen et al. 2005). The
lesions were neurochemically selective to 5-HT as
neither lesion had signiﬁcant eﬀects on DA content in
the target structure. This may indicate that treatment
with the DA reuptake inhibitor GBR12909 successfully
protected DA terminals. However, given the evidence
of DA/5-HT interactions (see below), compensatory
increases in DA levels following 5-HT depletion may
underlie this apparent sparing of DA content. Con-
sistent with this proposition, the shell lesion produced
signiﬁcant increases in both DA and DOPAC within
the core sample and the core lesion also increased
DOPAC levels within the CPu.
Both lesions led to reduced 5-HT levels in the
mPFC. We and others have also found changes in
mPFC DA levels after NAc 6-OHDA lesions (Nelson
et al. 2011a; Parkinson et al. 2002). Similarly, other
studies have shown comparable reductions in 5-HT
levels in the mPFC following 5,7-DHT lesions to the
NAc (Fletcher et al. 2009; Ludwig & Schwarting, 2007;
Mohr et al. 2009). It is not clear why 5,7-DHT lesions to
the NAc should produce 5-HT loss in distal regions
but simple diﬀusion of the neurotoxin is a poor ac-
count of these eﬀects as there were no signiﬁcant
changes in 5-HT content in the CPu which is dorsal to
the infusion site. In principle, the 5,7-DHT toxin may
have produced 5-HT depletion within the mPFC
through retrograde degeneration of the raphe nuclei
but the sparing of 5-HT content in the amygdala in-
dicates that this is unlikely. Perhaps more likely, the
neurotoxin may have been taken up by 5-HT trans-
porters on axons that pass through the NAc and which
in turn project to the mPFC (Fletcher et al. 2009;
Ludwig & Schwarting, 2007; Van Bockstaele et al.
1993; Zhou et al. 1998).
5,7-DHT lesions to the core attenuate LI
The 5,7-DHT lesion to the core disrupted the ex-
pression of LI as there was no diﬀerence in condition-
ing to the CS between the NPE and PE animals. This
ﬁnding may at ﬁrst seem surprising given the con-
siderable body of evidence demonstrating that both
electrolytic and excitotoxic lesions to the core spare or
potentiate LI depending on experimental parameters
(Gal et al. 2005). However, it is becoming increasingly
apparent that lesions that are neurochemically
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Fig. 2. The eﬀect of 5,7-DHT lesions to the core and shell of the
nucleus accumbens on latent inhibition produced with 10
conditioned-stimulus (CS) pre-exposures. Bars represent
suppression ratios (¡S.E.M.) to the CS for non-pre-exposed
controls (%) and pre-exposed animals ( ). Signiﬁcant
diﬀerence between pre-exposure groups (p<0.05).
Accumbal serotonin and latent inhibition 491selective can produce diﬀerent or even opposing ef-
fects on LI to those produced by standard lesioning
techniques. For example both electrolytic and ex-
citotoxic lesions to the shell NAc consistently abolish
LI (Gal et al. 2005; Tai et al. 1995; Weiner et al. 1996) but
we have found that 6-OHDA lesions to the shell spare
LI and under appropriate experimental parameters
(weak pre-exposure) actually enhance LI (Nelson
et al. 2011a,b). Similarly, we have also shown that
amphetamine exerts its disruptive eﬀects on LI via
actions in the core rather than shell NAc (Nelson et al.
2011a). According to the switching hypothesis of LI
(Weiner, 1990, 2003), the core mediates responding to
CS-reinforcement contingencies at conditioning and
the shell inhibits this core-based switching mechan-
ism. Within this framework, the current data suggest
that reducing 5-HT function within the core serves to
activate the switching mechanism so that the animal
responds according to the CS-reinforcement associ-
ation acquired at conditioning leading to disrupted LI.
This is turn suggests that within the core NAc, 5-HT
depletion produces a similar behavioural outcome as
that found after activation of DA.
There is a venerable history of research indicating
that 5-HT can modulate dopaminergic function in an
opposing manner (Lucki & Harvey, 1979). This work
broadly shows that increases in 5-HT can inhibit DA-
dependent behaviours while reducing 5-HT function
exerts the opposite eﬀect and enhances DA-dependent
behaviours (Fletcher, 1991, 1995; Fletcher et al. 1993,
1999; Wogar et al. 1991). Based on this evidence, re-
ducing the actions of 5-HT could be expected to pro-
duce the same behavioural outcome (disrupted LI) as
has been found with increasing DA release in the
NAc core (Joseph et al. 2000; Nelson et al. 2011a).
Interestingly, it appears that eﬀects of 5-HT depletion
on mesolimbic DA function and DA dependent-
behaviours are only seen when impulse-dependent
activation of DA neurons is required, that is calcium-
dependent phasic DA release in response to behav-
iourally relevant stimuli (Fletcher et al. 1999; Grace,
1991; Lyness & Moore, 1981). Similarly, impulse-
dependent DA release is required to disrupt LI
(Young et al. 2005). For example, LI is not disrupted
by direct DA agonists such as apomorphine, while
amphetamine given systemically or directly into
NAc core only abolishes LI when there has been
a previous sensitizing injection which promotes
calcium-dependent DA release (Feldon et al. 1991;
Joseph et al. 2000; Nelson et al. 2011a; Warburton et al.
1996). Thus the current ﬁndings of reduced LI after
5,7-DHT lesions to NAc core are consistent with the
eﬀects of 5-HT/DA opponent interactions and the
impulse-dependent release associated with this inter-
action.
5,7-DHT lesions to the shell potentiate LI
The behavioural results of the shell 5,7-DHT lesions
were markedly diﬀerent to those produced by the core
lesions as LI was enhanced rather than attenuated by
these lesions. Previously, reduced DA function in-
duced by either 6-OHDA lesions or microinfusions of
the D2 antagonist haloperidol has similarly been
shown to produce LI under conditions of weak pre-
exposure that do not yield LI in shams. We have re-
cently reported that the locus of these eﬀects within
the NAc is the medial shell (Nelson et al. 2011b). Thus
in the case of NAc shell, both 5-HT and DA depletion
appear to produce the same functional outcome.
Given the well-established evidence for 5-HT/DA
opponent interactions (see above) it may seem sur-
prising that 5-HT depletion can produce the same be-
havioural eﬀect as DA depletion. However, the nature
of this interaction may be inﬂuenced by several fac-
tors. First, the stimulatory eﬀect of 5-HT on DA may
depend on diﬀerent 5-HT receptor subtypes. In view
of the bewildering complexity of the multifarious pre-
and post-synaptic sites at which 5-HT acts, it is
perhaps not surprising that DA/5-HT interactions
cannot simply be deﬁned as opponent (for a review
see Alex & Pehek, 2007). For example within the NAc,
5-HT-induced increases in DA activity appear to be
modulated by 5-HT1A, 5-HT1B, 5-HT2A and 5-HT3 re-
ceptor subtypes (Jiang et al. 1990; Parsons & Justice,
1993; Yan & Yan, 2001; Yoshimoto & McBride, 1992).
Conversely, 5-HT2C receptors inhibit both tonic and
phasic DA release in NAc (Di Matteo et al. 2000).
Hence regional diﬀerences in the distribution of the
various 5-HT subtypes may inﬂuence the exact nature
of 5-HT/DA interactions. For example, there appears
to be a greater density of 5-HT2 and 5-HT4 receptors in
the shell relative to the core NAc (Zahm, 1999).
Second, the forebrain is innervated by two ana-
tomically distinct sets of 5-HT axons which may also
be functionally distinct (Mamounas et al. 1991).
Consistent with the subdivision of the NAc into core
and shell, there is good evidence that the 5-HT inner-
vation of the core and shell diﬀer in terms of density,
axon morphology and expression of the 5-HT trans-
porter SERT (Brown & Molliver, 2000). The sero-
tonergic axons of the shell lack SERT, are thicker
and more varicose relative to those of the core
(Van Bockstaele & Pickel, 1993). This distinct pattern
of 5-HT innervation to the core and shell NAc 5-HT
may also underlie functional diﬀerences. For example,
492 A. J. D. Nelson et al.core and shell 5-HT axons are diﬀerentially sensitive to
the neurotoxic eﬀects of methamphetamine (Brown &
Molliver, 2000). Thus regional diﬀerences in the mor-
phology of 5-HT axons in the NAc may also contribute
to the functional diﬀerences we have found after
selective serotonergic deaﬀerentation of the NAc.
It is possible that the enhancement of LI we found
following 5,7-DHT lesions to the shell was not in
fact mediated by changes in 5-HT within the shell but
rather by secondary changes in monoamines and their
metabolites that were observed in distal brain regions.
These changes were most pronounced in the mPFC
where there was a signiﬁcant loss of 5-HT. Although
lesions to the mPFC potentiate LI (George et al. 2010;
Nelson et al. 2010), the current results are most
unlikely to be due to these secondary changes in
mPFC 5-HT content as there was substantial loss of
mPFC 5-HT after both lesions and yet enhanced LI
was only seen in the shell lesion group. The 5,7-DHT
shell lesion also produced signiﬁcant increases in DA,
DOPAC and 5-HIAA in the core, as well as 5-HIAA
in the amygdala. However, increased DA function
within the core has been shown to disrupt rather
enhance LI (Nelson et al. 2011a) and although lesions
to the basolateral amygdala can potentiate LI (Schiller
& Weiner, 2004) it is unlikely that the moderate
increase in 5-HIAA observed in the current study can
account for the behavioural results found at test.
Conclusions
The current ﬁndings provide evidence of a marked
behavioural dissociation in the eﬀects of 5-HT de-
pletion within subregions of the NAc on the pro-
cessing of irrelevant stimuli. These data have
important implications for our understanding of
the neurobiological basis of LI. First, they show that
neurochemically selective lesions do not always pro-
duce the same pattern of results as obtained with
standard lesioning techniques. This is consistent with
what we have found with manipulations to forebrain
DA systems (Nelson et al. 2010; 2011a, b). Indeed, the
dissociation in function between the core and shell
found here is diametrically opposed to that which is
found with standard lesions (Gal et al. 2005; Tai et al.
1995; Weiner et al. 1996). Similarly, the demonstration
that both 6-OHDA and 5,7-DHT lesions to the shell
NAc enhance LI (Nelson et al. 2011a), suggests that
interactions between DA and 5-DHT in LI are more
complicated than has previously been assumed and
cannot be accommodated by a simple opponency
account. However, given the well-established role of
5-HT in the behavioural response to punishment
(Cools et al. 2008), it remains to be seen whether the
dissociable roles of core and shell 5-HT in modulating
the expression of LI would be found in an appetitively
motivated task. Although there is some evidence that
appetitive and aversive LI paradigms may share the
same neural substrates (Norman & Cassaday, 2004),
there is also evidence that the sensitivity of LI to vari-
ous neural manipulations can depend on the associ-
ative learning paradigm in use (Coutureau et al. 2001;
Pothuizen et al. 2006; Weiner et al. 1995). Thus further
experiments will be required to test the generality of
the current ﬁndings.
The current data complement emerging evidence
of the modulation of cognitive ﬂexibility by forebrain
serotonergic systems (Brigman et al. 2010; Clarke et al.
2004; Kehagia et al. 2010). Cognitive ﬂexibility can be
broadly deﬁned as the ability to modify behaviour
in response to changes in situational demands and
is mediated by fronto-striatal systems. Disrupted LI,
produced here by 5-HT depletion in the NAc core,
manifests as conditioning to stimuli that should nor-
mally be treated as irrelevant and amounts to excess-
ive behavioural switching. Conversely, enhanced LI
after deaﬀerentation of the 5-HT input to the shell
represents retarded behavioural switching and a
failure to switch cognitive resources to pertinent en-
vironmental stimuli. As such the current ﬁndings may
have important implications for understanding the
aetiology and treatment of disorders such as schizo-
phrenia that are marked by cognitive inﬂexibility.
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